Market Overview

Impax Labs Enters Commercialization Deal with Perrigo

Share:
Related PRGO
Digesting Delivering Alpha 2017: The Top Picks You Need To Know
Benzinga's Top Upgrades, Downgrades For September 7, 2017
Related IPXL
Wall Street's M&A Chatter From October 17: Sinclair, Impax Labs, WePay, Splunk-SignalSense
30 Stocks Moving In Tuesday's Mid-Day Session

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.

Posted-In: News

 

Related Articles (IPXL + PRGO)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...